SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-134200
Filing Date
2016-11-14
Accepted
2016-11-14 16:23:15
Documents
54
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q v451401_10q.htm 10-Q 412745
2 EXHIBIT 31.1 v451401_ex31-1.htm EX-31.1 11863
3 EXHIBIT 31.2 v451401_ex31-2.htm EX-31.2 11991
4 EXHIBIT 32.1 v451401_ex32-1.htm EX-32.1 5716
  Complete submission text file 0001144204-16-134200.txt   3304631

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mtnb-20160930.xml EX-101.INS 626596
6 XBRL TAXONOMY EXTENSION SCHEMA mtnb-20160930.xsd EX-101.SCH 36491
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mtnb-20160930_cal.xml EX-101.CAL 32487
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mtnb-20160930_def.xml EX-101.DEF 213138
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtnb-20160930_lab.xml EX-101.LAB 265808
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtnb-20160930_pre.xml EX-101.PRE 250807
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-193455 | Film No.: 161995087
SIC: 2834 Pharmaceutical Preparations